Author

H. Wilhelm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. H. C. van Kampen· 1 shared A. M. Aldejohann· 1 shared A. Noronha· 1 shared E. Sofyali· 1 shared H. Stieber· 1 shared K. Mueller-Decker· 1 shared L. Junghanns· 1 shared L. Magnani· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. H. C. van Kampen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The sphingolipid inhibitor myriocin increases susceptibility of Candida auris to amphotericin B

H. Stieber, L. Junghanns, H. Wilhelm, M. Batliner, A. M. Aldejohann, O. Kurzai, R. Martin

This study shows that myriocin, a sphingolipid inhibitor, increases susceptibility of Candida auris to amphotericin B and anidulafungin, suggesting sphingolipids as a target for overcoming resistance.

bioRxiv · Apr 14, 2022Microbiology

Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer

S. Borgoni, E. Sofyali, M. Soleimani Dodaran, H. Wilhelm, K. Mueller-Decker, R. Will, A. Noronha, P. J. Verschure, Y. Yarden, L. Magnani, A. H. C. van Kampen, P. D. Moerland, S. Wiemann

This study identifies ATF3 as a novel mediator of endocrine resistance in breast cancer through time-resolved profiling and validates its role in key signaling pathways and clinical relevance.

bioRxiv · Jun 8, 2020Cancer Biology